KAPPAPROCT Trademark

Trademark Overview

On Friday, May 18, 2012, a trademark application was filed for KAPPAPROCT with the United States Patent and Trademark Office. The USPTO has given the KAPPAPROCT trademark a serial number of 79113846. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, March 29, 2024. This trademark is owned by InDex Pharmaceuticals AB. The KAPPAPROCT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for human purposes, namely, pharmaceutical preparations for treating inflammatory diseases, and cancer
kappaproct

General Information

Serial Number79113846
Word MarkKAPPAPROCT
Filing DateFriday, May 18, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, March 29, 2024
Registration Number4366401
Registration DateTuesday, July 16, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2013

Trademark Statements

Goods and ServicesPharmaceuticals for human purposes, namely, pharmaceutical preparations for treating inflammatory diseases, and cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInDex Pharmaceuticals AB
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameInDex Pharmaceuticals AB
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameInDex Pharmaceuticals AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressSE

Trademark Events

Event DateEvent Description
Monday, September 10, 2012ASSIGNED TO EXAMINER
Thursday, June 28, 2012SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Saturday, June 30, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 4, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, September 11, 2012NON-FINAL ACTION WRITTEN
Wednesday, September 12, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 12, 2012REFUSAL PROCESSED BY MPU
Wednesday, September 12, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 24, 2012REFUSAL PROCESSED BY IB
Tuesday, February 19, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 19, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 12, 2013PAPER RECEIVED
Wednesday, March 13, 2013ASSIGNED TO LIE
Thursday, March 21, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 21, 2013AMENDMENT FROM APPLICANT ENTERED
Sunday, March 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 10, 2013NOTICE OF PUBLICATION
Wednesday, April 10, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 10, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, April 30, 2013PUBLISHED FOR OPPOSITION
Sunday, June 30, 2013NOTIFICATION PROCESSED BY IB
Tuesday, July 16, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, October 16, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 13, 2013FINAL DISPOSITION PROCESSED
Friday, December 13, 2013FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, February 11, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 17, 2014INTERNATIONAL REGISTRATION RENEWED
Friday, March 6, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, May 11, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 21, 2020CANCELLED SECTION 71
Wednesday, October 30, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, March 19, 2021INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Wednesday, October 21, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Related Keywords

kappaproct treating inflammatory diseases cancer preparations pharmaceutical human purposes namely pharmaceuticals